Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the RIETE Registry
By Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Jaime Luis Blasco Hernandez, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López Miguel, Manuel Monreal, and Cihan Ay
— On behalf of the RIETE Investigators
• The VTE-PREDICT score was designed to estimate recurrence and bleeding risks after acute VTE, but required validation in real-world populations.
• In 17 850 patients (median age 67 years; 64% with PE) from the RIETE registry, the model’s performance was tested for outcomes over 1–5 years under varied anticoagulant regimens.
• The score showed good discrimination for recurrence (c = 0.70–0.73) and moderate for bleeding (c = 0.65–0.67) but underestimated recurrence and overestimated bleeding in high-risk patients. Calibration refinement may enhance its clinical utility.”
Read the full article in JTH.
Article: External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmbὀlica Registry
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Luis Hernández-Blasco, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López-Miguel, Manuel Monreal, Cihan Ay
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies